37,000 AI Researchers Work 24/7 in Virtual Biotech to Discover Drugs

A large-scale AI-driven virtual biotech effort could accelerate drug discovery, but also raises concerns about AI-enabled biological capabilities.

Auto-scored: AI-driven drug discovery is a substantive medical advance, but the scale and autonomy of the system pose moderate dual-use risk.